Neoantigens for Personalized Cancer Vaccines: Comprehensive ID and Effective Selection

Neoantigens for Personalized Cancer Vaccines: Comprehensive ID and Effective Selection

Personalized Cancer Vaccines with Mark Poznansky, MD, PhDПодробнее

Personalized Cancer Vaccines with Mark Poznansky, MD, PhD

Neoantigen prediction and computational perspectives towards clinical benefitПодробнее

Neoantigen prediction and computational perspectives towards clinical benefit

Advances in Genomics and Personalized Immunotherapy, with Robert D. Schreiber, Ph.D.Подробнее

Advances in Genomics and Personalized Immunotherapy, with Robert D. Schreiber, Ph.D.

Neoantigen Vaccine With Pembrolizumab Has Clear Benefit in Resected MelanomaПодробнее

Neoantigen Vaccine With Pembrolizumab Has Clear Benefit in Resected Melanoma

Personalized Cancer Vaccines and Cellular Therapy in Solid TumorsПодробнее

Personalized Cancer Vaccines and Cellular Therapy in Solid Tumors

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer VaccinesПодробнее

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer Vaccines

NGS Best Practices for Developing Personalized Neoantigen VaccinesПодробнее

NGS Best Practices for Developing Personalized Neoantigen Vaccines

Harnessing Neoantigens for Individualized Cancer ImmunotherapyПодробнее

Harnessing Neoantigens for Individualized Cancer Immunotherapy

Efficient Selection of Tumor Associated Neoantigens in the Design of Personalized Cancer VaccinesПодробнее

Efficient Selection of Tumor Associated Neoantigens in the Design of Personalized Cancer Vaccines

MIA: Sisi Sarkizova, Michael Rooney, Improving endogenous antigen prediction for cancer vaccinesПодробнее

MIA: Sisi Sarkizova, Michael Rooney, Improving endogenous antigen prediction for cancer vaccines

Beatriz Carreno: Personalized Cancer VaccinesПодробнее

Beatriz Carreno: Personalized Cancer Vaccines

The future of personalized, neoantigen cancer vaccinesПодробнее

The future of personalized, neoantigen cancer vaccines

Developing Personalized Cancer Neoantigen VaccinesПодробнее

Developing Personalized Cancer Neoantigen Vaccines

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer VaccinesПодробнее

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer Vaccines

Neoantigen Summit: Supercharging Immunotherapies & Cancer VaccinesПодробнее

Neoantigen Summit: Supercharging Immunotherapies & Cancer Vaccines

2021 Neoantigen Summit EU Maik PruessПодробнее

2021 Neoantigen Summit EU Maik Pruess

Unlocking the potential of personalized neoantigen vaccines with ACE ImmunoID™Подробнее

Unlocking the potential of personalized neoantigen vaccines with ACE ImmunoID™

Neoantigen Targeting in Cancer Immunotherapy: Current Strategies and Future DirectionsПодробнее

Neoantigen Targeting in Cancer Immunotherapy: Current Strategies and Future Directions

Targeting Tumor Mutations for Personalized Cancer ImmunotherapyПодробнее

Targeting Tumor Mutations for Personalized Cancer Immunotherapy